Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Oct 18, 2013 in Colorectal cancer | 0 comments

In a nutshell

This trial investigated the association between physical activity and the risk of recurrence (return of the cancer) and survival in patients with colon cancer (cancer of the large intestine).

Some background

The treatments of colon cancer have improved significantly over the years. However, many patients still have high risks for cancer recurrence and their survival rate is generally less than 2 years after recurrence. Previous studies have shown that physical activity can reduce up to 50% the risk of disease recurrence in patients with colon cancer. Due to the high mortality of patients with recurrent disease, this trial investigated how physical activity can have a positive impact on colon cancer patients with recurrent disease. 

Methods & findings

This study included 273 patients with recurrent disease after treatment for advanced colon cancer. Physical activity was measured approximately 6 months after completion of the treatment, but before recurrence of the disease. Results showed that patients who reported at least 18 hours a week of physical activity had a 29% higher likelihood of survival after colon cancer recurrence compared to patients who reported less than 3 hours a week of physical activity. No differences in survival were found between genders, weight, age and chemotherapy treatments received. 

The bottom line

In summary, this study showed that physical activity after treatment can improve the prognosis (survival) of patients with recurrent colon cancer. 

What’s next?

Consult with your doctor about the most appropriate physical activity plan in your situation. 

Published By :

Clinical Colorectal Cancer

Date :

Sep 10, 2013

Original Title :

Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance.

click here to get personalized updates